Literature DB >> 7490271

Aberrant expressions of decorin and biglycan genes in the carbohydrate-deficient glycoprotein syndrome.

J Gu1, Y Wada.   

Abstract

Carbohydrate-deficient glycoprotein syndrome (CDGS) is a congenital disorder characterized by neurological and developmental defects. We have examined the expressions of the small proteoglycans decorin and biglycan in cultured skin fibroblasts from a patient with CDGS Type-I. Northern blotting analysis identified a marked reduction in decorin mRNA and an increase in biglycan mRNA levels. The decorin protein in the culture medium was decreased. Responses to interleukin-1 beta (IL-1 beta) and transforming growth factor-beta 1 (TGF-beta 1) were apparently abnormal; decorin was only slightly up-regulated by IL-1 beta, while biglycan was markedly down-regulated by IL-1 beta and significantly up-regulated by TGF-beta 1. The constitutional and developmental abnormalities characteristic of CDGS may be associated with such derangements in the expression of proteoglycan genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490271     DOI: 10.1093/oxfordjournals.jbchem.a124855

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Carbohydrate deficient glycoprotein (CDG) syndrome type I.

Authors:  J Jaeken; G Matthijs; R Barone; H Carchon
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

Review 2.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

3.  Regulation of vimentin expression and protease-mediated vimentin degradation during differentiation of human monocytic leukemia cells.

Authors:  K Honke; Y Wada
Journal:  Jpn J Cancer Res       Date:  1997-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.